title: Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings.
abstract: The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.
authors.affiliation: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Kengo
authors.initials: K
authors.lastname: Tanabe
authors.forename: Angela
authors.initials: A
authors.lastname: Hoye
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Lemos
authors.forename: Jiro
authors.initials: J
authors.lastname: Aoki
authors.forename: Chourmouzios A
authors.initials: CA
authors.lastname: Arampatzis
authors.forename: Francesco
authors.initials: F
authors.lastname: Saia
authors.forename: Chi-hang
authors.initials: CH
authors.lastname: Lee
authors.forename: Muzzafer
authors.initials: M
authors.lastname: Degertekin
authors.forename: Sjoerd H
authors.initials: SH
authors.lastname: Hofma
authors.forename: Georgios
authors.initials: G
authors.lastname: Sianos
authors.forename: Eugene
authors.initials: E
authors.lastname: McFadden
authors.forename: Pieter C
authors.initials: PC
authors.lastname: Smits
authors.forename: Willem J
authors.initials: WJ
authors.lastname: van der Giessen
authors.forename: Pim
authors.initials: P
authors.lastname: de Feyter
authors.forename: Ron T
authors.initials: RT
authors.lastname: van Domburg
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000401:mortality* / Q000473:pathology; D005260:Female; D005431:Florida; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012042:Registries; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus